Holding Pharmaceutical Companies Responsible for Putting Patients at Risk
Pradaxa® was first introduced as a prescription drug in October of 2010. It is a blood thinner that is prescribed to patients with atrial fibrillation. This condition causes an irregular heartbeat in...
View ArticleJ&J Takes A Fall: Can the Public Put Their Trust in Major Pharmaceutical...
For decades, Johnson & Johnson has been a corporate pillar in the pharmaceutical industry. After being hit with multiple product liability lawsuits, it appears that the company’s rock-solid...
View ArticleA Concerning Letter from Johnson & Johnson: TVM and Your Safety
As far back as 2007, Johnson & Johnson had been warned by the Food and Drug Administration (FDA) to discontinue marketing its Gynecare Prolift® transvaginal mesh (TVM) implant. The vaginal mesh is...
View ArticlePradaxa Litigation Consolidated in Federal Court
Mass torts — cases in which a large number of individuals suffer harm due to a single instance of negligence — present numerous legal and administrative issues. In order to handle these cases quickly,...
View Article
